Slow vaccine rollout a threat to Sub-Sahara

Economic growth in SubSaharan Africa will lag world output partly because of the slow rollout of coronavirus vaccines, with more delays to immunisation raising chances the disease will become an endemic problem, according to the IMF.

The regional economy will probably expand 3.7% in 2021, after shrinking 1.7% in 2020, when restrictions to curb the spread of Covid-19 weighed on activity and trade, the lender said on Thursday in its economic outlook for Sub-Saharan Africa.

The rebound will be slower than in advanced economies, with the divergence in growth expected to persist to the end of 2023, Abebe Aemro Selassie, director of the Washingtonbased IMF’s Africa department, said in an interview on Monday.

“Instead of catching up and closing the gap in income, what we see is the region falling short of where things were on the eve of the pandemic,” he said. The outlook is reflective of different access to vaccines and “stark differences” in the availability of policy support, the lender said.

Africa is the world’s least inoculated region, with only 5.23% of its 1.2-billion people fully immunised against the disease, Africa Centres for Disease Control and Prevention data show. The IMF’s baseline outlook assumes that only a few Sub-Saharan African countries will achieve widespread vaccine availability before 2023, though demand for booster shots in advanced economies could compromise supply, it said.

“Further delays to the rollout would leave Sub-Saharan Africa exposed to new, more virulent strains of the virus, raising the prospect that Covid-19 will ultimately become a permanent, endemic problem across the region — inevitably weighing on confidence, growth and the

strength of the recovery,” it said.

An internationally endemic disease that leads to an adjustment in behaviour by companies and households and affects regional vaccine programmes could cost Sub-Saharan Africa an additional 1.5% of GDP over the four years from 2022, according to the lender.

Differing prospects for countries in the region also reflect divergent vaccine programmes and fiscal and monetary policy support, and show how diversified economic structures muted the effects of the virus and helped some to quickly adapt to changes, the lender said.

The region’s low-income countries require $245bn in additional funding over the next five years to secure a robust recovery and regain lost ground

the corresponding figure for all of Sub-Saharan Africa is $425bn, the IMF said.

While special drawing rights (SDR) allocated by the IMF to its members in August have boosted the region’s reserves, voluntary channelling of SDRs to countries in need from those with strong external assets can magnify the effect of the new allocations, it said.

Options to rechannel the assets include through the fund’s Poverty Reduction and Growth Trust, which gives interest-free loans, and the creation of a Resilience and Sustainability Trust, which could help lowincome and vulnerable middleincome countries move towards more climate-friendly futures, Selassie said.

Talks about a third option, in which the assets could be directed towards prescribed SDR holders such as the World Bank, are in the early stages, he said.

FURTHER DELAYS TO THE ROLLOUT WOULD LEAVE SUB-SAHARAN AFRICA EXPOSED TO NEW, MORE VIRULENT STRAINS OF THE VIRUS